These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21077716)

  • 21. Evaluation of new antimicrobials for the hospital formulary. Policies restricting antibiotic use in hospitals.
    Pujol M; Delgado O; Puigventós F; Corzo JE; Cercenado E; Martínez JA
    Enferm Infecc Microbiol Clin; 2013 Sep; 31 Suppl 4():45-50. PubMed ID: 24129289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals.
    Bergstrom CT; Lo M; Lipsitch M
    Proc Natl Acad Sci U S A; 2004 Sep; 101(36):13285-90. PubMed ID: 15308772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibiotic resistance is selected primarily in our patients.
    Péchère JC
    Infect Control Hosp Epidemiol; 1994 Jul; 15(7):472-7. PubMed ID: 7963439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibiotic Restriction Might Facilitate the Emergence of Multi-drug Resistance.
    Obolski U; Stein GY; Hadany L
    PLoS Comput Biol; 2015 Jun; 11(6):e1004340. PubMed ID: 26110266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A pilot study of antibiotic cycling in the community hospital setting.
    Bruno-Murtha LA; Brusch J; Bor D; Li W; Zucker D
    Infect Control Hosp Epidemiol; 2005 Jan; 26(1):81-7. PubMed ID: 15693413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Therapeutic antibiotics for postoperative infection: antibiotic heterogeneity].
    Fukushima R
    Nihon Geka Gakkai Zasshi; 2006 Sep; 107(5):219-23. PubMed ID: 17017417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A review of the role of antibiotic policies in the control of antibiotic resistance.
    Gould IM
    J Antimicrob Chemother; 1999 Apr; 43(4):459-65. PubMed ID: 10350373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of Antibiotic-Resistant Pathogens in Culture-Proven Sepsis and Outcomes Associated With Inadequate and Broad-Spectrum Empiric Antibiotic Use.
    Rhee C; Kadri SS; Dekker JP; Danner RL; Chen HC; Fram D; Zhang F; Wang R; Klompas M;
    JAMA Netw Open; 2020 Apr; 3(4):e202899. PubMed ID: 32297949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can antibiotic-resistant nosocomial infections be controlled?
    Farr BM; Salgado CD; Karchmer TB; Sherertz RJ
    Lancet Infect Dis; 2001 Aug; 1(1):38-45. PubMed ID: 11871409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies of antibiotic resistance within the patient, hospitals and the community using simple mathematical models.
    Austin DJ; Anderson RM
    Philos Trans R Soc Lond B Biol Sci; 1999 Apr; 354(1384):721-38. PubMed ID: 10365398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fighting antibiotic resistance in the intensive care unit using antibiotics.
    Plantinga NL; Wittekamp BH; van Duijn PJ; Bonten MJ
    Future Microbiol; 2015; 10(3):391-406. PubMed ID: 25812462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of de-escalation of beta-lactam antibiotics on the emergence of antibiotic resistance in ICU patients: a retrospective observational study.
    De Bus L; Denys W; Catteeuw J; Gadeyne B; Vermeulen K; Boelens J; Claeys G; De Waele JJ; Decruyenaere J; Depuydt PO
    Intensive Care Med; 2016 Jun; 42(6):1029-39. PubMed ID: 27025939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efforts of pharmacy to reduce antibiotic resistance.
    Klem C; Dasta JF
    New Horiz; 1996 Aug; 4(3):377-84. PubMed ID: 8856756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microbes have the last word. A drastic re-evaluation of antimicrobial treatment is needed to overcome the threat of antibiotic-resistant bacteria.
    Davies J
    EMBO Rep; 2007 Jul; 8(7):616-21. PubMed ID: 17603533
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of a "handshake" stewardship program versus a formulary restriction policy on High-End antibiotic use, expenditure, antibiotic resistance, and patient outcome.
    Moghnieh R; Awad L; Abdallah D; Jadayel M; Sinno L; Tamim H; Jisr T; El-Hassan S; Lakkis R; Dabbagh R; Bizri AR
    J Chemother; 2020 Nov; 32(7):368-384. PubMed ID: 32364030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for antibiotic cycling in control of resistance.
    Pujol M; Gudiol F
    Curr Opin Infect Dis; 2001 Dec; 14(6):711-5. PubMed ID: 11964889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of collateral sensitivity networks to design drug cycling protocols that avoid resistance development.
    Imamovic L; Sommer MO
    Sci Transl Med; 2013 Sep; 5(204):204ra132. PubMed ID: 24068739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical efficacy of cycling empirical antibiotic therapy for febrile neutropenia in pediatric cancer patients.
    Teranishi H; Koga Y; Nishio H; Kato W; Ono H; Kanno S; Nakashima K; Takada H
    J Infect Chemother; 2017 Jul; 23(7):463-467. PubMed ID: 28527651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pervasive and diverse collateral sensitivity profiles inform optimal strategies to limit antibiotic resistance.
    Maltas J; Wood KB
    PLoS Biol; 2019 Oct; 17(10):e3000515. PubMed ID: 31652256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mathematical model for the transport of fluoroquinolone and its resistant bacteria in aquatic environment.
    Gothwal R; Thatikonda S
    Environ Sci Pollut Res Int; 2018 Jul; 25(21):20439-20452. PubMed ID: 28780691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.